Climate action and carbon neutrality: ClimatePartner introduces solutions for companies of all sizes and industries
Proven SaaS solution enables companies to take immediate climate action Established and acknowledged solution for…
Proven SaaS solution enables companies to take immediate climate action Established and acknowledged solution for…
The first museum for immersive art in Switzerland is opening with a world premiere: Viva…
Over one hundred engineers to be hired in multiple locations Munich Germany, September 21st, 2021…
Tim Dargavel has joined the UK’s most innovative legal document bundling group Zylpha (www.Zylpha.com) as…
Regulatory approvals in South Korea, the fourth largest pharma market in Asia, and Panama Maxigesic®…
REGULATED INFORMATION Gosselies, Belgium, 21 September 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris:…
New Dupixent® (dupilumab) data in patients as young as 6 years old with moderate-to-severe atopic…
WALTHAM, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical…
MELBOURNE, Australia and INDIANAPOLIS, Sept. 20, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…
HONG KONG and FLORHAM PARK, N.J., Sept. 20, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited…
TIVDAK is a First-in-Class Antibody-Drug Conjugate Directed to Tissue Factor, a Protein Expressed on Cervical…
CALGARY, Alberta, Sept. 20, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…
FOSTER CITY, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation…
BOSTON, Sept. 20, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
CAMBRIDGE, Mass., Sept. 20, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company…
Cash and cash equivalents at €93.6 m as of June 30, 2021 compared to…
SAN DIEGO, Sept. 20, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical…
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to…
No Specific Deficiencies Related to the Manufacturing of VP-102 Identified by FDA in its General…